Tong Ren Tang announced that Tong Ren Tang Pharmaceutical Co., Ltd., a branch of the company, has received a “Product License” approved and issued by the Canadian Ministry of Health, and that three products have obtained Canadian product registration: peony oligosaccharide capsules, Gusi Yanzong pills, and pregnancy promotion pills. If the above products are to be sold in Canada, administrative examination and approval matters such as certification of the Canadian production quality system at the production site must be completed in the future, and there is some uncertainty about the approval. This approval will not have a significant impact on the company's recent business performance. Overseas sales are affected by many factors such as policies and markets. Investors are kindly requested to pay attention to investment risks.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.